Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $148,596 - $170,781
2,900 Added 64.44%
7,400 $401,000
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $231,705 - $367,380
4,500 New
4,500 $264,000
Q4 2021

Feb 14, 2022

SELL
$47.97 - $62.21 $215,865 - $279,945
-4,500 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$54.64 - $61.3 $245,880 - $275,850
4,500 New
4,500 $255,000
Q4 2019

Feb 12, 2020

SELL
$36.31 - $46.83 $294,111 - $379,323
-8,100 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$35.66 - $44.99 $117,677 - $148,467
-3,300 Reduced 28.95%
8,100 $324,000
Q2 2019

Aug 20, 2019

SELL
$36.57 - $47.97 $10,971 - $14,391
-300 Reduced 2.56%
11,400 $496,000
Q1 2019

May 15, 2019

SELL
$36.47 - $42.17 $36,470 - $42,170
-1,000 Reduced 7.87%
11,700 $445,000
Q4 2018

Feb 14, 2019

BUY
$41.31 - $52.16 $524,637 - $662,432
12,700 New
12,700 $540,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.